Avotres

Cedar Knolls, United States

Avotres is a biotechnology company that provides therapeutic solutions for immunologically mediated disorders.

$4.0M raised

May 2023

Debt Financing

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Avotres raised?

Avotres has raised $4.0M in total funding. The most recent round was Debt Financing. The last funding was announced in May 2023.

Who are Avotres's investors?

Avotres's investors include Prox Ventures.

Where is Avotres headquartered?

Avotres is headquartered in Cedar Knolls, United States.

What does Avotres do?

Avotres is a biotechnology company that provides therapeutic solutions for immunologically mediated disorders.

What stage is Avotres at?

Avotres is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 4, 2023.

MLA

"Avotres — Funding & Investors." VCBacked, May 4, 2023, https://www.vcbacked.co/company/avotres. Accessed July 2, 2026.

APA

VCBacked. (2023). Avotres — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/avotres

Wikipedia (cite web)

{{cite web |title=Avotres — Funding & Investors |url=https://www.vcbacked.co/company/avotres |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 4, 2023.